Menu Back to Global-AE-Reporting-Drug-Safety-Requirements-in-the-US-and-EU

Program Committee

  • JP  Clement, MD
    Representative Invited JP Clement Pharmacovigilance Consulting, United States
  • Steve  Jolley, MA
    Representative Invited SJ Pharma Consulting, LLC, United States
  • Andre  Daniels, MD, MS
    Representative Invited Amgen, Inc., United States
  • Sylvie  Tomczyk, MD, PhD
    Representative Invited EMD Serono, United States
Load More